» Articles » PMID: 23761898

Gene X Abstinence Effects on Drug Cue Reactivity in Addiction: Multimodal Evidence

Overview
Journal J Neurosci
Specialty Neurology
Date 2013 Jun 14
PMID 23761898
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Functional polymorphisms in the dopamine transporter gene (DAT1 or SLC6A3) modulate responsiveness to salient stimuli, such that carriers of one 9R-allele of DAT1 (compared with homozygote carriers of the 10R-allele) show heightened reactivity to drug-related reinforcement in addiction. Here, using multimodal neuroimaging and behavioral dependent variables in 73 human cocaine-addicted individuals and 47 healthy controls, we hypothesized and found that cocaine-addicted carriers of a 9R-allele exhibited higher responses to drug cues, but only among individuals who had used cocaine within 72 h of the study as verified by positive cocaine urine screens (a state characterized by intense craving). Importantly, this responsiveness to drug cues was reliably preserved across multimodal imaging and behavioral probes: psychophysiological event-related potentials, self-report, simulated cocaine choice, and fMRI. Because drug cues contribute to relapse, our results identify the DAT1R 9R-allele as a vulnerability allele for relapse especially during early abstinence (e.g., detoxification).

Citing Articles

Genomic factors associated with substance use disorder relapse: A critical review.

Al-Marzooqi N, Al-Suhail H, AlRefai M, Alhaj H Addict Behav Rep. 2024; 20:100569.

PMID: 39553284 PMC: 11568783. DOI: 10.1016/j.abrep.2024.100569.


The Incentive-Sensitization Theory of Addiction 30 Years On.

Robinson T, Berridge K Annu Rev Psychol. 2024; 76(1):29-58.

PMID: 39094061 PMC: 11773642. DOI: 10.1146/annurev-psych-011624-024031.


Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.

Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork J, Claus E JAMA Psychiatry. 2024; 81(4):414-425.

PMID: 38324323 PMC: 11304510. DOI: 10.1001/jamapsychiatry.2023.5483.


A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.

Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes A, Kaufman M, Oliver J Nat Protoc. 2022; 17(3):567-595.

PMID: 35121856 PMC: 9063851. DOI: 10.1038/s41596-021-00649-4.


Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.

Blum K, Bowirrat A, Braverman E, Baron D, Cadet J, Kazmi S Int J Environ Res Public Health. 2021; 18(21).

PMID: 34770047 PMC: 8582845. DOI: 10.3390/ijerph182111529.


References
1.
van Dyck C, Malison R, Jacobsen L, Seibyl J, Staley J, Laruelle M . Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med. 2005; 46(5):745-51. View

2.
Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R . Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry. 2009; 166(10):1170-7. PMC: 2875882. DOI: 10.1176/appi.ajp.2009.08121801. View

3.
Ray L, Bryan A, MacKillop J, McGeary J, Hesterberg K, Hutchison K . The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol. 2008; 14(2):238-44. PMC: 3151559. DOI: 10.1111/j.1369-1600.2008.00120.x. View

4.
Dreher J, Kohn P, Kolachana B, Weinberger D, Berman K . Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A. 2008; 106(2):617-22. PMC: 2626752. DOI: 10.1073/pnas.0805517106. View

5.
Gainetdinov R, Jones S, Caron M . Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry. 1999; 46(3):303-11. DOI: 10.1016/s0006-3223(99)00122-5. View